- A large new study found Regeneron’s monoclonal antibody cocktail reduces the risk of hospitalization and death from COVID-19 in high-risk patients, the pharmaceutical company announced in a statement Tuesday.
- Researchers looked at more than 4,000 recently diagnosed patients and found the two-antibody combo drug, called REGEN-COV, cut the risk of hospitalization or death by 70% and reduced the median recovery time from 14 days to 10.
- “This is a landmark moment in the fight against COVID-19,” said Dr Suraj Saggar, trial investigator and chief of infectious disease at Holy Name Medical Center in Teaneck, New Jersey. “With so many people will getting infected … these data underscore the need to rapidly adopt REGEN-COV as standard-of-care to offer high-risk patients their best chance to reduce serious consequences.”
- North Carolina Gov. Roy Cooper on Tuesday eased several restrictions that will soon allow businesses to open at greater capacity and more people to assemble indoors and outdoors. Starting Friday, bars and sports and entertainment venues can open at 50% capacity indoors or outdoors, and the 11 p.m. cutoff for on-site alcohol consumption will be fully lifted.
- Miami Beach plans to extend a state of emergency for the entertainment district to control spring break crowds. The extension, expected to be announced Tuesday, will authorize a curfew.
- Thursday night through early Monday that could be extended every week through April 13, Melissa Berthier, spokesperson for Miami Beach, told USA TODAY. Slightly more than half of those arrested at Miami Beach over a period including spring break live outside of Florida, city data shows.
US’ Supreme Court takes the side of college athletes in opposition to NCAA
The US supreme court has governed in support of student-athletes. They were in a reparation row with the NCAA (National...
